Advancing the diagnosis of epithelioid hemangioendothelioma by 18F-FDG PET/CT

Weijun Wei; Gang Huang; Jianjun Liu

Advancing the diagnosis of epithelioid hemangioendothelioma by ¹⁸F-FDG PET/CT

Am J Nucl Med Mol Imaging. 2021 Jun 15;11(3):230-232. eCollection 2021.

Authors

Weijun Wei¹, Gang Huang^{1

2}, Jianjun Liu¹

Affiliations

¹ Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.
² Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences Shanghai, China.

PMID: 34235001
PMCID: PMC8255213

Abstract

Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor originating from endothelial cells. Since ultrasound findings of EHE are nonspecific, computed tomography (CT) and magnetic resonance imaging (MRI) are routinely used for diagnosing the disease. Accumulating evidence indicates that ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) has implemental value in diagnosing EHE. In this Perspective, we outline the most recent evidence reporting the diagnostic value of ¹⁸F-FDG PET/CT in EHE. The combinational use of CT, MRI, and ¹⁸F-FDG PET/CT may help clinicians diagnose the disease in its earlier stages.

Keywords: 18F-fluorodeoxyglucose; Epithelioid hemangioendothelioma; positron emission tomography/computed tomography.

Publication types

Editorial